Overslaan en naar de inhoud gaan


Nucleaire Geneeskunde (Seminarie)

Outcome prediction to treatment with 177Lu-PSMA-RLT in men with metastatic castration resistant prostate cancer. Retrospective analysis from a monocentric cohort." Docteur Elisa Barraco

Meet the Oncology Expert

Precision medicine, and precision management in rare cancers : the model of sarcomas - Prof Jean-Yves Blay

Meet the Oncology Expert

Clinical development of innovative therapeutic anti-cancer vaccines ? Olivier ADOTEVI, MD PhD ,Regional Cancer Institute of Franche-Comté

Meet the Oncology Expert

AI in pathology: from sandbox to implementation in clinical practice (Paul J. Van DIEST, MD PhD (The Netherlands)